DOJ Re-Brands Guidance Documents
FDA Law Blog
AUGUST 29, 2021
This policy, announced by then Associate Attorney General Rachel Brand in 2018 was referred to as the Brand Memo. As a matter of administrative law, the Brand Memo made good sense from the perspective of FDA-regulated industry, as we described here. The memorandum cites the 2019 Supreme Court decision, Kisor v.
Let's personalize your content